Consort Medical plc Company Profile (LON:CSRT)

Analyst Ratings

Consensus Ratings for Consort Medical plc (LON:CSRT) (?)
Ratings Breakdown: 3 Hold Rating(s), 4 Buy Rating(s)
Consensus Rating:Buy (Score: 2.57)
Consensus Price Target: GBX 1,105

Analysts' Ratings History for Consort Medical plc (LON:CSRT)
Show:
DateFirmActionRatingPrice TargetActions
6/17/2016Numis Securities LtdReiterated RatingUnder ReviewView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/16/2016Stifel NicolausReiterated RatingBuyGBX 1,200View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/16/2016InvestecBoost Price TargetBuyGBX 1,150 -> GBX 1,170View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/16/2016Canaccord GenuityReiterated RatingBuyGBX 1,150View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/16/2016Panmure GordonReiterated RatingBuyGBX 1,145View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/4/2016Royal Bank Of CanadaInitiated CoverageSector PerformerGBX 1,150View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/3/2015N+1 SingerReiterated RatingHoldGBX 933View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/20/2015FinnCapUpgradeHoldGBX 730 -> GBX 987View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/1/2015Shore CapitalReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/29/2015Edison Investment ResearchReiterated RatingNo Rating SystemGBX 1,061View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/24/2014Deutsche Bank AGReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/28/2014 forward)

Earnings

Earnings History for Consort Medical plc (LON:CSRT)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Consort Medical plc (LON:CSRT)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Consort Medical plc (LON:CSRT)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable DateShare
6/16/2016GBX 12.561.33%9/22/20169/22/201610/21/2016Tweet This Announcement  Share This Announcement on StockTwits
12/3/2015GBX 6.750.64%1/14/20161/14/20162/12/2016Tweet This Announcement  Share This Announcement on StockTwits
6/16/2015GBX 11.681.23%9/24/20159/24/201510/23/2015Tweet This Announcement  Share This Announcement on StockTwits
12/4/2014GBX 6.430.83%1/15/20151/15/20152/13/2015Tweet This Announcement  Share This Announcement on StockTwits
6/17/2014GBX 13.351.53%9/17/20149/17/201410/24/2014Tweet This Announcement  Share This Announcement on StockTwits
12/4/2013GBX 7.350.82%1/15/20141/15/20142/14/2014Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Consort Medical plc (LON:CSRT)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/22/2016Cotton,RichardInsiderSell55,153GBX 992£547,117.76Tweet This Trade  Share This Trade on StockTwits
3/15/2016Ginman-Jones,CharlottaInsiderBuy948GBX 1,048£9,935.04Tweet This Trade  Share This Trade on StockTwits
9/15/2015Glenn,JonathanInsiderSell3,234GBX 960£31,046.40Tweet This Trade  Share This Trade on StockTwits
7/30/2015Crummett,SteveInsiderBuy1,000GBX 929£9,290Tweet This Trade  Share This Trade on StockTwits
7/1/2015Cotton,RichardInsiderSell24,146GBX 9.13£2,204.53Tweet This Trade  Share This Trade on StockTwits
1/6/2015Jonathan GlennInsiderSell67,000GBX 845£566,150Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Consort Medical plc (LON:CSRT)
DateHeadline
07/13/16 03:34 PMCantor Fitzgerald disclosed (LON:CSRT) Consort Medical PLC, holding steady its stock price target at 1,180GBX today
07/05/16 03:11 PMConsort Medical Plc : Undervalued relative to peers, but don’t ignore the other factors -
06/21/16 10:24 AMConsort Medical Plc – Value Analysis (LONDON:CSRT) : June 21, 2016 -
06/20/16 03:36 AMConsort Medical Plc breached its 50 day moving average in a Bullish Manner : CSRT-GB : June 20, 2016 -
06/17/16 06:09 PMDEV610 update - [at noodls] - Consort Medical plc 16 June 2016 DEV610 is a dry powder inhaler initially for use in Mylan's generic version of Advair which they have submitted for US approval FDA has set potential approval date (GDUFA ...
06/17/16 10:14 AMConsort Medical PLC (LON:CSRT) stock price target bumped up to GBX1,170 as disclosed today by Investec
06/16/16 07:50 AMConsort Medical FY Pre-tax Profit Rises
06/16/16 07:50 AMNew product delays drag on Consort Medical
06/16/16 07:50 AMConsort Medical PLC (LON:CSRT) stock price target held steady to GBX1,145 as announced today by Panmure Gordon
06/16/16 06:07 AMFull Year 2016 Consort Medical PLC Earnings Release - Before Market Open -
06/09/16 10:42 AMConsort Medical plc (CSRT) Given Buy Rating at Panmure Gordon
03/02/16 03:33 AMConsort Medical Plc breached its 50 day moving average in a Bullish Manner : CSRT-GB : March 2, 2016 -
02/22/16 11:12 AMConsort Medical agrees partnership and invests in Precision Ocular -
01/29/16 03:31 AMConsort Medical Plc breached its 50 day moving average in a Bullish Manner : January 29, 2016 -
01/15/16 03:32 AMConsort Medical Plc breached its 50 day moving average in a Bearish Manner : January 15, 2016 -
12/17/15 12:11 PMConsort Medical Plc Earnings Analysis: H1, 2015 By the Numbers -
10/12/15 03:29 AMCONSORT MEDICAL LAUNCHES NEW BRAND IDENTITY TO THE MARKET - [at noodls] - Following the recent acquisition of Aesica Pharmaceuticals by Consort Medical, the company is pleased to announce the launch of a new brand identity today to align the companies and communicate the consolidated ...
02/24/15 06:06 PMVoke® licence - variation granted by MHRA - [at noodls] - News Release 23 February 2015 Voke® nicotine inhaler licence - variation granted by MHRA Hemel Hempstead, UK, 23 February 2015 - Consort Medical plc (LSE: CSRT) ("Consort", "Consort Medical" ...
02/05/15 06:06 PMIntegrated Dose Counter Supply Agreement - [at noodls] - News Release 4 February 2015 Consort Medical plc signs multi-year supply agreement for its proprietary integrated dose counter (IDC) system First agreement for oral variant of IDC-containing device Significant ...
01/30/15 07:55 PM£2.2m investment in Atlas Genetics Series C - [at noodls] - News Release 29 January 2015 Consort Medical plc invests £2.2m in Atlas Genetics Series C Funding Funding to accelerate global launch of Atlas io® molecular testing system Hemel Hempstead, UK, January ...
01/29/15 01:00 AMAtlas Genetics Completes $20m Series C Fundraising - [PR Newswire] - BATH, England, January 29, 2015 /PRNewswire/ -- Atlas Genetics Ltd ("Atlas" or the "Company"), the ultra-rapid "test and treat" molecular diagnostics company, today announces ...
09/12/14 07:07 AMBAT's novel e-cigarette rival wins UK medical approval -

Social

About Consort Medical plc

Consort Medical plc logoConsort Medical plc is a contract development and manufacturing organization (CDMO). The Company is engaged in providing delivery technologies, formulation and manufacturing solutions for drugs. The Company operates through two divisions: Bespak and Aesica. The Bespak division develops and manufactures drug delivery devices to deliver drugs to sufferers of asthma and chronic obstructive pulmonary disease (COPD). The Bespak division provides pharmaceutical companies with inhaler and auto-injector technologies, and development and manufacturing services. The Aesica division is a pharmaceutical CDMO, which provides pharmaceutical companies with active pharmaceutical ingredients (APIs) and finished dose formulation development and manufacturing services. It offers development services, contract manufacturing, generics and other services for APIs, and formulation development services, such as pre-formulation, formulation and manufacturing, and analysis and stability testing, among others.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: LON
  • Symbol: CSRT
  • CUSIP:
Key Metrics:
  • Previous Close: $13.49
  • 50 Day Moving Average: $1022.31
  • 200 Day Moving Average: $1008.51
  • P/E Ratio: 33.56
  • P/E Growth: 0.28
  • Market Cap: $503.46M
  • Current Year EPS Consensus Estimate: $56.92 EPS
  • Next Year EPS Consensus Estimate: $N/A EPS
Additional Links: